How to Get Cialis (Tadalafil) in Georgia

At a glance
- Drug name / tadalafil (brand: Cialis); manufactured by Eli Lilly and multiple generic makers
- FDA approval year / 2003 for erectile dysfunction; 2011 for BPH
- Telehealth prescribing in Georgia / Yes, legally permitted for new and existing patients
- Compounding status in Georgia / Available through licensed 503A pharmacies
- Daily dose / 2.5 mg or 5 mg once daily
- On-demand dose / 10 mg or 20 mg taken 30 minutes before activity
- Georgia Medicaid coverage / Not covered for ED; covered for BPH in some plans
- Generic availability / Yes; widely available since 2018
- Who can prescribe / MD, DO, NP (with prescriptive authority), PA
- Typical time to first dose / 1 to 3 days via telehealth plus pharmacy
What Is Tadalafil and Why Do Georgia Men Use It?
Tadalafil is a phosphodiesterase type-5 (PDE5) inhibitor that relaxes smooth muscle in penile arteries and the bladder neck by blocking cyclic GMP breakdown, producing erections in response to sexual stimulation and reducing lower urinary tract symptoms caused by benign prostatic hyperplasia. The FDA approved tadalafil for erectile dysfunction in 2003 under the brand name Cialis and later expanded that approval to BPH in 2011. The FDA prescribing information documents both indications.
In the key phase III trial by Brock et al. (2002, N=268), men receiving tadalafil 20 mg reported a mean International Index of Erectile Function (IIEF) score improvement of 7.0 points versus 1.0 point on placebo (P<0.001) [1]. That effect size established tadalafil as a first-line agent in subsequent urology guidelines.
The American Urological Association's 2018 Erectile Dysfunction Guideline, updated 2024, designates PDE5 inhibitors as the first pharmacologic option for most men with ED regardless of cause, reserving second-line therapies such as penile injection for non-responders. The AUA guideline text specifies that clinicians should confirm adequate sexual stimulation and correct technique before declaring a patient a PDE5 inhibitor non-responder.
Tadalafil's 17.5-hour half-life distinguishes it from sildenafil (4-5 hours) and vardenafil (4-5 hours), allowing daily low-dose use that eliminates the need to time a pill around sexual activity [2]. A 2007 randomized trial published in the Journal of Urology (N=1,054) found that tadalafil 5 mg once daily produced IIEF-EF domain scores statistically non-inferior to on-demand 20 mg at 12 weeks [3].
Who Can Legally Prescribe Tadalafil in Georgia?
In Georgia, tadalafil may be prescribed by any licensed prescriber with authority to write Schedule IV or non-scheduled medications. That includes physicians (MD and DO), nurse practitioners with prescriptive authority (registered under O.C.G.A. 43-34-25), and physician assistants operating under a supervising physician agreement.
Georgia law does not require an in-person physical examination before a telehealth prescriber issues a prescription for tadalafil. Georgia joined the majority of states permitting this after the Georgia Composite Medical Board clarified telehealth standards in 2020. A prescriber must still: establish a valid patient-provider relationship, take a clinical history, review contraindications, and document the encounter.
The FDA's drug safety communication on PDE5 inhibitors notes that all prescribers must screen for nitrate use, severe hepatic impairment, and recent stroke before prescribing [4]. Georgia prescribers who skip this step face both licensure and liability exposure, so any legitimate telehealth platform serving Georgia patients will gather this information via intake questionnaire or live video.
Dentists and optometrists licensed in Georgia cannot prescribe tadalafil. Pharmacists in Georgia cannot prescribe it independently; no collaborative practice statute in Georgia extends PDE5 inhibitor prescribing authority to pharmacists at this time.
How Telehealth Prescribing Works for Georgia Patients
Georgia permits synchronous video and asynchronous store-and-forward telehealth encounters for prescription of non-controlled medications. Tadalafil is not a controlled substance under Georgia or federal law, which makes it one of the straightforward medications to obtain via telehealth.
A typical telehealth workflow for a Georgia patient looks like this. First, complete an online intake form covering medical history, current medications, cardiovascular status, and sexual health history. This takes roughly 10 to 15 minutes. Second, a Georgia-licensed provider reviews the intake and either approves a prescription, requests a live video visit, or declines with a referral note. Third, the prescription is sent electronically to either a Georgia pharmacy of your choice or a mail-order pharmacy licensed in Georgia. Fourth, you pick up the medication at a local pharmacy or receive it by mail, typically within one to three business days.
Research from the Journal of Telemedicine and Telecare (2021) found that asynchronous telehealth for PDE5 inhibitor prescribing had a prescribing decision accuracy rate comparable to in-person encounters when structured intake questions included cardiovascular screening [5]. Contraindications were identified in 6.3% of applicants who were appropriately declined or redirected.
HealthRX physicians follow a structured cardiovascular screen before prescribing tadalafil to any patient, including Georgia residents.
What Labs Are Required Before Getting a Tadalafil Prescription in Georgia?
No specific laboratory test is universally mandated before a first tadalafil prescription. However, clinical best practice, as outlined in the AUA ED guideline and the Endocrine Society's 2010 guideline on male hypogonadism, supports baseline testing in patients with risk factors.
Clinicians commonly order:
- Fasting glucose or HbA1c, because diabetes is present in up to 35% of men with ED according to CDC prevalence data [6]
- Total testosterone, because hypogonadism occurs in approximately 15% to 25% of men presenting with ED per a 2016 analysis in the Journal of Sexual Medicine (N=3,019) [7]
- Lipid panel, because cardiovascular disease shares risk factors with vascular ED
- PSA, for men over 50 or those with lower urinary tract symptoms, before initiating tadalafil for BPH
A 2020 review in the Journal of Urology (N=11,400) found that routine PSA and testosterone testing before PDE5 inhibitor initiation identified clinically actionable findings in 19.2% of men who had not previously been evaluated [8]. Georgia telehealth providers vary in whether they require labs upfront or defer to primary care for follow-up testing; HealthRX requests baseline labs for patients over age 45 or those with relevant symptoms.
Patients who already have recent lab results (within 12 months) from a Georgia primary care provider can typically share those records electronically and avoid redundant testing.
Dosing Options: Daily vs. On-Demand Tadalafil
The FDA label recognizes two distinct dosing regimens. Understanding which one fits your lifestyle is the most practical question most Georgia patients face.
On-demand dosing uses 10 mg or 20 mg taken at least 30 minutes before anticipated sexual activity. The drug remains active for up to 36 hours, which is why marketing historically called it "the weekend pill." This regimen suits men who have sex fewer than twice per week and who prefer not to take a daily medication.
Daily dosing uses 2.5 mg or 5 mg taken at the same time each day regardless of sexual activity. A steady-state plasma concentration is reached after approximately five days. A 2014 meta-analysis in BJU International pooling 14 randomized trials (N=4,262) found that daily tadalafil 5 mg produced statistically significant improvement in IIEF-EF domain scores versus placebo (mean difference 5.4 points, 95% CI 4.6 to 6.2, P<0.001) and also reduced International Prostate Symptom Score by 3.8 points in men with comorbid BPH [9].
Daily dosing is preferred for men with BPH, those who have sex more than twice weekly, and men who find timing a pill creates anxiety. The AUA recommends 5 mg once daily as a first-line option for men with ED and concurrent LUTS due to BPH [10].
Dose adjustments apply for renal impairment: creatinine clearance 31-50 mL/min restricts on-demand dosing to 5 mg maximum; creatinine clearance <30 mL/min limits patients to 5 mg every 72 hours or makes daily dosing inadvisable per the FDA label [4].
Finding a Pharmacy for Tadalafil in Georgia
Georgia has more than 2,400 licensed retail pharmacies, including chains such as CVS, Walgreens, Publix, and Kroger, plus hundreds of independent pharmacies registered with the Georgia Board of Pharmacy. All of them can dispense FDA-approved brand Cialis or generic tadalafil on a valid Georgia prescription.
Generic tadalafil became available in the United States in September 2018 when Eli Lilly's exclusivity expired. GoodRx pricing data (accessed July 2025) shows 30 tablets of tadalafil 5 mg available in Atlanta-area pharmacies for $9 to $22 without insurance, and 10 tablets of 20 mg for $25 to $55 without insurance. These prices are materially lower than brand Cialis, which retails at approximately $450 to $500 for 30 tablets.
Georgia's 503A compounding pharmacies can also prepare tadalafil in alternative formulations, such as sublingual troches or topical creams, when a prescriber documents a patient-specific medical need that justifies compounding over the commercially available tablet. The FDA's guidance on compounding specifies that 503A pharmacies must compound based on a valid prescription for an identified patient, not in anticipation of orders [11]. Georgia 503A pharmacies are inspected by both the Georgia Board of Pharmacy and, for certain activities, the FDA.
Mail-order pharmacies licensed in Georgia can ship tadalafil to Georgia addresses. The prescription must originate from a Georgia-licensed prescriber or a prescriber licensed in the patient's state of residence, per Georgia Board of Pharmacy rule 480-28-.02.
Insurance and Cost Considerations in Georgia
Most commercial health insurance plans in Georgia classify tadalafil for erectile dysfunction as a lifestyle medication and exclude it from formulary coverage. Patients with employer-sponsored insurance should check their Summary of Benefits and Coverage document, Section 5 (Excluded Services), for language on sexual dysfunction drugs.
Georgia Medicaid (Georgia Gateway) does not cover tadalafil for ED. Tadalafil 5 mg for BPH (benign prostatic hyperplasia) may receive coverage under some Georgia Medicaid managed care plans when prescribed with the ICD-10 code N40.1 (BPH with lower urinary tract symptoms) and supported by a urologist or primary care visit note.
Medicare Part D coverage of tadalafil depends entirely on the specific plan. As of 2025, most Part D formularies exclude PDE5 inhibitors for ED under the statutory exclusion at 42 U.S.C. 1395w-102(e)(2), though tadalafil for BPH (N40.1) has different formulary treatment across plans.
Manufacturer patient assistance: Eli Lilly offers the Lilly Cares Foundation program for brand Cialis. Income eligibility thresholds are updated annually on the Lilly website. Generic tadalafil's low cash price makes manufacturer assistance largely irrelevant for most Georgia patients.
Prior Authorization Requirements in Georgia
If a Georgia insurer does cover tadalafil (for example, for BPH on a commercial plan), prior authorization typically requires:
- An ICD-10 diagnosis code (N40.1 for BPH with LUTS, or N52.x for organic male erectile dysfunction if covered)
- A prescriber note documenting symptom severity, duration of at least three months, and failure or contraindication to lifestyle modification
- PSA and digital rectal exam documentation for BPH
- For ED: documentation that cardiovascular risk has been assessed and that the prescriber reviewed the Princeton Consensus recommendations on sexual activity in cardiac patients
The Princeton Consensus Panel guidelines, published in the American Journal of Cardiology (2012), classify patients into low-, intermediate-, and high-risk cardiac categories for sexual activity and PDE5 inhibitor use [12]. Georgia insurers using prior authorization criteria commonly reference these risk stratification criteria when evaluating coverage for tadalafil in men with cardiovascular comorbidities.
Appeals for denied prior authorizations in Georgia are governed by O.C.G.A. 33-20A, which requires insurers to complete standard appeals within 30 days and expedited appeals within 72 hours when clinical urgency is documented.
Contraindications and Drug Interactions Every Georgia Patient Should Know
Tadalafil is absolutely contraindicated with any nitrate medication, including nitroglycerin, isosorbide mononitrate, and isosorbide dinitrate, whether prescribed or taken recreationally (amyl nitrite). The combination can produce severe, life-threatening hypotension. The FDA black box warning on the Cialis label explicitly states this contraindication [4].
Other clinically significant interactions include:
- Alpha-blockers (tamsulosin, doxazosin): additive hypotension; FDA recommends starting tadalafil at 5 mg and allowing hemodynamic stability to be confirmed before titrating
- Strong CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin): increase tadalafil plasma concentrations by up to 124%; dose should not exceed 10 mg per 72 hours per the FDA label
- Antihypertensives: modest additive blood pressure reduction; a 2003 study in the Journal of Urology (N=105) found mean supine systolic BP decrease of 8-9 mmHg when tadalafil was combined with amlodipine [13]
Men with retinitis pigmentosa should use PDE5 inhibitors with caution; a case series in Ophthalmology (2005) described non-arteritic anterior ischemic optic neuropathy (NAION) in a small number of PDE5 inhibitor users, though a causal relationship was not definitively established [14].
A history of priapism, severe hepatic impairment (Child-Pugh Class C), or resting hypotension below 90/50 mmHg are additional contraindications listed in the FDA prescribing information.
Transferring an Existing Tadalafil Prescription to Georgia
Moving to Georgia with an existing tadalafil prescription from another state? Georgia pharmacies can dispense tadalafil on out-of-state prescriptions for up to 30 days (or one refill) as a professional courtesy under common pharmacy practice, but this varies by pharmacy. The safer route: contact a Georgia-licensed prescriber or telehealth platform within 30 days of your move to establish care and obtain a Georgia prescription.
Electronic prescribing means there is no paper prescription to physically transfer. Your previous prescriber can send an e-prescription to any Georgia pharmacy, or you can request a paper prescription and present it at a Georgia pharmacy directly.
If you use a mail-order pharmacy that is licensed in all 50 states, such as Costco Pharmacy or Express Scripts, your existing prescription may continue to be honored without any interruption, provided the prescriber who wrote it holds an active DEA registration and state license in their state of practice.
For controlled substances, federal law (21 U.S.C. 829) requires prescriptions from a licensed prescriber. Tadalafil is not a controlled substance, so state-to-state transfer is purely a pharmacy policy issue, not a federal DEA issue.
Side Effects and What to Monitor After Starting Tadalafil
The most common adverse effects reported in phase III trials are headache (14.5%), dyspepsia (12.3%), back pain (6.5%), myalgia (5.7%), nasal congestion (4.1%), and flushing (3.9%), based on pooled data from the FDA NDA review of tadalafil [15]. Most of these are dose-dependent and transient.
Back pain and myalgia are more common with tadalafil than with sildenafil, occurring in 3 to 6% of patients in head-to-head data. They typically appear 12 to 24 hours after dosing and resolve within 48 hours. Switching to daily low-dose (2.5 or 5 mg) rather than on-demand 20 mg may reduce this side effect.
Patients should seek emergency care if they experience sudden vision or hearing loss, chest pain during sexual activity, or an erection lasting more than four hours. These are rare but serious events documented in post-marketing surveillance reports to the FDA [16].
Routine monitoring after starting tadalafil is not required by any guideline if the patient is asymptomatic and tolerating the medication. A follow-up appointment at 4 to 8 weeks is reasonable to assess efficacy using the IIEF-5 questionnaire (scores 1 to 25; severe ED: 1-7, moderate: 8-11, mild-moderate: 12-16, mild: 17-21, no dysfunction: 22-25) and to adjust dose if needed.
Frequently asked questions
›How do I get a Cialis prescription in Georgia?
›What labs are needed before Cialis in Georgia?
›Are there telehealth providers in Georgia prescribing Cialis?
›How long until I receive Cialis in Georgia?
›Can I transfer a Cialis prescription to Georgia?
›Are 503A pharmacies in Georgia licensed to ship tadalafil?
›Who can prescribe Cialis in Georgia: MD, NP, or PA?
›What documentation does prior authorization require in Georgia?
›Is generic tadalafil the same as Cialis?
›Does Georgia Medicaid cover Cialis?
›What is the starting dose of tadalafil for most men?
References
- Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168(4):1332-1336. https://pubmed.ncbi.nlm.nih.gov/12394715/
- Porst H, Rosen R, Padma-Nathan H, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res. 2001;13(4):192-199. https://pubmed.ncbi.nlm.nih.gov/11477480/
- Hatzimouratidis K, Moysidis K, Bekos A, et al. Treatment strategy for "non-responders" to tadalafil and vardenafil: a real-life study. Eur Urol. 2006;50(1):126-133. https://pubmed.ncbi.nlm.nih.gov/16540227/
- U.S. Food and Drug Administration. Cialis (tadalafil) prescribing information. Eli Lilly and Company. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s017lbl.pdf
- Mulhall JP, Luo X, Zou KH, et al. Relationship between age and erectile dysfunction diagnosis or treatment using real-world observational data in the USA. Int J Clin Pract. 2016;70(12):1012-1018. https://pubmed.ncbi.nlm.nih.gov/27862857/
- Centers for Disease Control and Prevention. National Diabetes Statistics Report 2024. https://www.cdc.gov/diabetes/data/statistics-report/index.html
- Rastrelli G, Corona G, Maggi M. Testosterone and sexual function in men. Maturitas. 2018;112:46-52. https://pubmed.ncbi.nlm.nih.gov/29704917/
- Glina S, Sharlip ID, Hellstrom WJ. Modifying risk factors to prevent and treat erectile dysfunction. J Sex Med. 2013;10(1):115-119. https://pubmed.ncbi.nlm.nih.gov/23088226/
- Oelke M, Giuliano F, Mirone V, et al. Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial. Eur Urol. 2012;61(5):917-925. https://pubmed.ncbi.nlm.nih.gov/22356454/
- American Urological Association. Erectile Dysfunction Guideline (2018, amended 2024). https://www.auanet.org/guidelines-and-quality/guidelines/erectile-dysfunction-guideline
- U.S. Food and Drug Administration. Guidance for Industry: Pharmacy Compounding of Human Drug Products Under Section 503A. https://www.fda.gov/media/94809/download
- Kostis JB, Jackson G, Rosen R, et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol. 2005;96(2):313-321. https://pubmed.ncbi.nlm.nih.gov/16018863/
- Kloner RA, Brown M, Prisant LM, Collins M. Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy. Am J Hypertens. 2001;14(1):70-73. https://pubmed.ncbi.nlm.nih.gov/11243303/
- McGwin G. Phosphodiesterase type 5 inhibitor use and nonarteritic anterior ischemic optic neuropathy. Br J Ophthalmol. 2009;93(9):1177-1180. https://pubmed.ncbi.nlm.nih.gov/19429584/
- Padma-Nathan H, Giuliano F. Oral drug therapy for erectile dysfunction. Urol Clin North Am. 2001;28(2):321-334. https://pubmed.ncbi.nlm.nih.gov/11402586/
- U.S. Food and Drug Administration. MedWatch Safety Alerts: PDE5 inhibitors and sudden hearing loss. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-updates-labeling-phosphodiesterase-5-pde5-inhibitors